|
CYB5D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.392200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.282200E-01 |
| Normal-vs-Stage2 |
9.783800E-01 |
| Normal-vs-Stage3 |
9.283700E-02 |
| Normal-vs-Stage4 |
9.052000E-02 |
| Stage1-vs-Stage2 |
7.754600E-01 |
| Stage1-vs-Stage3 |
8.016200E-02 |
| Stage1-vs-Stage4 |
2.015200E-01 |
| Stage2-vs-Stage3 |
2.771600E-01 |
| Stage2-vs-Stage4 |
3.082000E-01 |
| Stage3-vs-Stage4 |
8.870600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.017400E-01 |
| Normal-vs-AfricanAmerican |
8.553600E-01 |
| Normal-vs-Asian |
4.732400E-01 |
| Caucasian-vs-AfricanAmerican |
7.037000E-01 |
| Caucasian-vs-Asian |
4.092600E-01 |
| AfricanAmerican-vs-Asian |
4.305600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.173200E-01 |
| Normal-vs-Female |
8.105400E-01 |
| Male-vs-Female |
8.572200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.750170E-01 |
| Normal-vs-Extreme_Weight |
6.325800E-01 |
| Normal-vs-Obese |
4.847800E-01 |
| Normal-vs-Extreme_Obese |
9.058400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.402400E-01 |
| Normal_Weight-vs-Obese |
1.014590E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.902600E-01 |
| Extreme_Weight-vs-Obese |
3.807800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.370400E-01 |
| Obese-vs-Extreme_Obese |
6.840000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.761800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.429700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.606400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.366400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.443000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.765200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.700400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.670090E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.003500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.855830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.209700E-04 |
| Normal-VS-Type2 PRCC |
8.983600E-04 |
| Normal-VS-KIRP CIMP |
1.134170E-02 |
| Normal-VS-Unclassified PRCC |
9.664000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.25519999633661E-08 |
| Type1 PRCC-VS-KIRP CIMP |
5.175600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.153700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.491000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.714000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.533500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.836800E-01 |
| Normal-vs-N1 |
9.039700E-02 |
| Normal-vs-N2 |
3.87389997857923E-09 |
| N0-vs-N1 |
5.563400E-01 |
| N0-vs-N2 |
9.61600000000118E-05 |
| N1-vs-N2 |
4.195800E-02 |
|
|
